Our results clearly demonstrated that WDR79 knockdown in NSCLC cells increased the level of Bax, while concomitantly decreasing Bcl‐2 levels, which lowered the ratio of Bcl‐2 to Bax. The gene discussed is BAX; the disease is non-small cell lung carcinoma.